Financial Engines Advisors L.L.C. Citius Pharmaceuticals, Inc. Transaction History
Financial Engines Advisors L.L.C.
- $48.7 Billion
- Q3 2024
A detailed history of Financial Engines Advisors L.L.C. transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Financial Engines Advisors L.L.C. holds 20,000 shares of CTXR stock, worth $51,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000Holding current value
$51,800% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CTXR
# of Institutions
61Shares Held
23.7MCall Options Held
83.1KPut Options Held
32.1K-
Armistice Capital, LLC New York, NY7.28MShares$18.8 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.44MShares$16.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.88MShares$4.87 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$4.68 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.16MShares$3 Million0.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $378M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...